The effects of combined treatment with the novel vitamin D analogue MC 1288 and cyclosporine A on cardiac allograft survival
- 30 September 1995
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 3 (3) , 245-250
- https://doi.org/10.1016/0966-3274(95)80031-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in miceTransplant Immunology, 1993
- Potentiation of immunosuppressive effects of cyclosporin A by 1α,25-dihydroxyvitamin D3Cellular Immunology, 1989
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- ABOLITION OF THE EFFECT OF CYCLOSPORINE ON RAT CARDIAC ALLOGRAFT REJECTION BY THE NEW IMMUNOMODULATOR LS-2616 (LINOMIDE)Transplantation, 1989
- 1,25‐Dihydroxyvitamin D3 POtentiates the in vitro inhibitory effects of cyclosporin A on T cells from rheumatoid arthritis patientsArthritis & Rheumatism, 1989
- Granulocyte-macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes.Journal of Clinical Investigation, 1987
- Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.Journal of Clinical Investigation, 1987
- Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol).Journal of Clinical Investigation, 1984
- 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.Journal of Clinical Investigation, 1984